<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">TAZAROTENE</span><br/>(ta-zar'o-teen)<br/><span class="topboxtradename">Avage, </span><span class="topboxtradename">Tazorac<br/></span><b>Classifications:</b> <span class="classification">skin and mucous membrane agent</span>; <span class="classification">antiacne</span>; <span class="classification">retinoid</span><br/><b>Prototype: </b>Isotretinoin<br/><b>Pregnancy Category: </b>X<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.05%, 0.1% gel, cream</p>
<h1><a name="action">Actions</a></h1>
<p>Retinoid prodrug that blocks epidermal cell proliferation and hyperplasia. Mechanism of action in acne is not known.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Suppresses inflammation present in the epidermis of psoriasis patients. Indicated by improvement in acne or psoriasis; effective
         in treatment of mild to moderate acne.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Topical treatment of plaque psoriasis on up to 20% of the body, mild to moderate acne, facial fine wrinkling, mottled
         hypo- and hyperpigmentation (blotchy skin discoloration), and benign facial lentigines.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to tazarotene; pregnancy (category X), women who are or may become pregnant.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Concurrent administration with drugs that are photosensitizers (e.g., thiazide diuretics, tetracyclines). Lactation. Safety
         and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Plaque Psoriasis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply thin film to affected area once daily in evening<br/><br/><span class="indicationtitle">Acne</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> After cleansing and drying face, apply thin film to acne lesions once daily in evening<br/><br/><span class="indicationtitle">Fine Wrinkles</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply thin film of cream to affected area once daily<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Dry skin completely before application of a thin film of medication.</li>
<li>Apply medication to no more than 20% of body surface in those with psoriasis.</li>
<li>Apply only to affected areas; avoid contact with eyes and mucous membranes.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> <span class="speceff-common">Pruritus, burning/stinging, erythema, worsening of psoriasis, irritation, skin pain,</span> rash, desquamation of skin, irritant contact dermatitis, inflammation, fissuring, bleeding, dry skin, sunburn. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Increased risk of photosensitivity reactions with <span class="classification">quinolones</span> (especially <b>sparfloxacin</b>), <span class="classification">phenothiazines</span>, <span class="classification">sulfonamides</span>, <span class="classification">sulfonylureas</span>, <span class="classification">tetracyclines</span>, <span class="classification">thiazide diuretics</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed through skin. <span class="typehead">Distribution:</span> Active metabolite &gt;99% protein bound; crosses placenta, distributed into breast milk. <span class="typehead">Metabolism:</span> Undergoes esterase hydrolysis to active metabolite AGN 190299. <span class="typehead">Elimination:</span> Eliminated in both urine and feces. <span class="typehead">Half-Life:</span> 18 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for photosensitivity in those concurrently using any of the following: thiazides, tetracyclines, fluoroquinolones,
            phenothiazines, sulfonamides.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Understand fully the risk of serious fetal harm. Use reliable forms of effective contraception. Discontinue treatment and
            notify physician if pregnancy occurs.
         </li>
<li>Alert: Immediately rinse thoroughly with water if contact with eyes occurs.</li>
<li>Avoid all unnecessary exposure to sunlight or artificial UV light. If brief exposure is necessary, cover as much skin surface
            as possible and use sunscreens (minimum SPF 15).
         </li>
<li>Do not apply to sunburned skin.</li>
<li>Discontinue medication and notify physician if any of the following occur: pruritus, burning, skin redness, excessive peeling,
            worsening of psoriasis.
         </li>
<li>Limit application of topicals with strong skin-drying effects to skin areas being treated with tazarotene.</li>
<li>Do not breast feed while using this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>